Search Results

Cresilon, Inc. has entered into a Cooperative Research and Development Agreement (“CRADA”) with Walter Reed Army Institute of Research (“WRAIR”), the largest biomedical research facility administered by the U.S. Department of Defense (“DoD”), to advance the development of medical technologies used for treating traumatic brain injuries, particularly those sustained by soldiers on the battlefield.

Adaptive Phage Therapeutics today announced that it has entered into a licensing agreement with The Walter Reed Army Institute of Research (WRAIR) to provide APT access to the Institute’s extensive phage database.